Once the stent is implanted and hooked up, those tiny sensor dots can start listening to the brain's signals. Depending on how close you are to each individual neuron, you can hear activity that relates to certain functions. To record those changes in the flow of electrons, the device needs to be as close to the brain as possible. Synchron does that by going into the jugular vein in the neck.
Startups pioneering invasive and noninvasive devices that interact with the brain seek to alleviate everything from ALS symptoms to epilepsy to treatment-resistant depression. In this episode, a look at the science behind this rapidly advancing technology.
Dr. Thomas Oxley, a neurointerventionist and CEO of Synchron, gives us a tour of his lab in Brooklyn, New York, where his company is developing an implant that allows paralyzed people to control devices.
Then Bloomberg reporter Sarah McBride joins Wes for a look at other startups making these brain-computer interfaces–and where the industry goes from here.
Listen to The Big Take podcast every weekday and subscribe to our daily newsletter: https://bloom.bg/3F3EJAK
Have questions or comments for Wes and the team? Reach us at bigtake@bloomberg.net.
See omnystudio.com/listener for privacy information.